🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Mihaela Aldea

Université Paris-Saclay

ORCID: 0000-0001-7685-051X

Also affiliated with Institut Gustave Roussy

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile
0.258Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Brief Report: Clinical Characteristics and Outcomes of Patients With Thoracic SMARCA4-Deficient Undifferentiated Tumors

JTO Clinical and Research Reports(2024)10.1016/j.jtocrr.2024.100759
Top 59%
0.258DataRank
Top 59%4 citations

Andrea Arfè, Biagio Ricciuti, Andréanne Gagné, Lynette M. Sholl, Alessandro Di Federico +19 more

Papers

Driven by 8 papers — median percentile 41. Top paper: “Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC”.

Comutations and KRASG12C Inhibitor Efficacy in Advanced NSCLC

Cancer Discovery(2023)10.1158/2159-8290.cd-22-1420
N/A
0.787DataRank · unranked
189 citations

Haniel A. Araújo, Giuseppe Lamberti, Alissa J. Cooper, Neal S. Akhave, Teng Zhou +61 more

End-To-End Clinical Trial Matching with Large Language Models

arXiv (Cornell University)(2024)10.48550/arxiv.2407.13463
N/A
0.396DataRank · unranked
13 citations

Lars Hilgers, Isabella C. Wiest, Marie-Elisabeth Leßmann, Jan Clusmann, Peter Neidlinger +11 more

Meta-Analysis on the Combination of Chemotherapy With Programmed Death-Ligand 1 and Programmed Cell Death Protein 1 Blockade as First-Line Treatment for Unresectable Pleural Mesothelioma

Journal of Thoracic Oncology(2024)10.1016/j.jtho.2023.08.004
N/A
0.373DataRank · unranked
11 citations

Massimo Di Maio, Jordi Remon, Paolo Bironzo, Carlo Genova, Francesco Facchinetti +7 more

First-Line MET Tyrosine Kinase Inhibitors versus Immunotherapy ± Chemotherapy for Patients with MET Exon 14 Skipping Mutant Metastatic NSCLC

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-1735
N/A
0.345DataRank · unranked
9 citations

Hui Li, Alessandro Di Federico, Jia Wu, Hong Chen, Eleonora Gariazzo +26 more

Molecular Tumor Boards: A Consensus Statement From the International Association for the Study of Lung Cancer

Journal of Thoracic Oncology(2025)10.1016/j.jtho.2025.07.009
N/A
0.309DataRank · unranked
6 citations

Julia Rotow, Maria E. Arcila, M. Hatton, Lynette M. Sholl, Christian Rolfo +35 more

Activating Mutations in the MET Kinase Domain Co-Occur With Other Driver Oncogenes and Mediate Resistance to Targeted Therapy in NSCLC

Journal of Thoracic Oncology(2025)10.1016/j.jtho.2025.03.045
N/A
0.292DataRank · unranked
6 citations

Federica Pecci, Biagio Ricciuti, Felix H. Gottlieb, Francesco Facchinetti, Guilherme Harada +21 more

Brief Report: Clinical Characteristics and Outcomes of Patients With Thoracic SMARCA4-Deficient Undifferentiated Tumors

JTO Clinical and Research Reports(2024)10.1016/j.jtocrr.2024.100759
Top 59%
0.258DataRank
Top 59%4 citations

Andrea Arfè, Biagio Ricciuti, Andréanne Gagné, Lynette M. Sholl, Alessandro Di Federico +19 more

Artificial intelligence-based biomarkers for treatment decisions in oncology

Trends in cancer(2025)10.1016/j.trecan.2024.12.001
N/A
0DataRank · unranked
50 citations

Omar S. M. El Nahhas, Mihaela Aldea, Jakob Nikolas Kather, Marta Ligero